Forward Pharma A/S

Symbol: FWPAY

PNK

300

USD

Market price today

  • -3.8756

    P/E Ratio

  • -0.0010

    PEG Ratio

  • 7.45M

    MRK Cap

  • 0.00%

    DIV Yield

Forward Pharma A/S (FWPAY) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.00%

Operating Profit Margin

0.00%

Net Profit Margin

0.00%

Return on Assets

-0.03%

Return on Equity

-0.03%

Return on Capital Employed

-0.05%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Dr. Claus Bo Søndergaard Svendsen M.D., Ph.D.
Full-time employees:4
City:Copenhagen
Address:Oestergade 24A
IPO:2014-10-15
CIK:

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Return on Investments

The company's asset efficiency, represented by a robust -0.026% return, is a testament to Forward Pharma A/S's adeptness in optimizing resource deployment. Forward Pharma A/S's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.025%. Furthermore, the proficiency of Forward Pharma A/S in capital utilization is underscored by a remarkable -0.055% return on capital employed.

Liquidity Ratios

Analyzing FWPAY liquidity ratios reveals its financial health of the firm. The current ratio of 11743.75% gauges short-term asset coverage for liabilities. The quick ratio (11662.83%) assesses immediate liquidity, while the cash ratio (11639.80%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio11743.75%
Quick Ratio11662.83%
Cash Ratio11639.80%

Profitability Ratios

The effective tax rate stands at -9.94%, revealing its tax efficiency. The net income per EBT, 100.00%, and the EBT per EBIT, 48.84%, provide insights into its earnings hierarchy.

cards.indicatorcards.value
Effective Tax Rate-9.94%
Net Income per EBT100.00%
EBT per EBIT48.84%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 117.44, it details the span from stock purchase to revenue. The 117 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding11663

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -96.51, and free cash flow per share, -96.51, depict cash generation on a per-share basis. The cash per share value, 2895.43, showcases liquidity position.

cards.indicatorcards.value
Operating Cash Flow per Share-96.51
Free Cash Flow per Share-96.51
Cash per Share2895.43
Free Cash Flow to Operating Cash Flow Ratio1.00

Per Share Data

Net income per share, -77.41, reflects the portion of profit attributed to each share. The book value per share, 2896.53, represents the net asset value distributed per share, while the tangible book value per share, 2896.53, excludes intangible assets.

cards.indicatorcards.value
Net Income Per Share-77.41
Book Value Per Share2896.53
Tangible Book Value Per Share2896.53
Shareholders Equity Per Share2896.53

Growth Ratios

EBIT growth, -14.41%, and operating income growth, -14.41%, offer insights into operational profitability progression. The net income growth, 70.66%, showcases bottom-line expansion, and the EPS growth, 71.19%, measures the growth in earnings per share.

cards.indicatorcards.value
EBIT Growth-14.41%
Operating Income Growth-14.41%
Net Income Growth70.66%
EPS Growth71.19%
EPS Diluted Growth71.19%
Weighted Average Shares Growth1.85%
Weighted Average Shares Diluted Growth1.85%
Operating Cash Flow Growth58.71%
Free Cash Flow Growth58.71%
5-Year Operating CF Growth per Share61.75%
3-Year Operating CF Growth per Share84.55%
5-Year Net Income Growth per Share68.61%
3-Year Net Income Growth per Share78.99%
5-Year Shareholders Equity Growth per Share151.28%
3-Year Shareholders Equity Growth per Share-16.61%
Receivables Growth-51.22%
Asset Growth-10.42%
Book Value per Share Growth-11.61%
R&D Expense Growth-30.89%
SGA Expenses Growth19.25%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, -22,130,420, captures the company's total value, considering both debt and equity. Income quality, 1.25, assesses the reliability of reported earnings.

cards.indicatorcards.value
Enterprise Value-22,130,420
Income Quality1.25
Graham Number2246.07
Return on Tangible Assets-2.65%
Graham Net Net2874.85
Working Capital70,794,000
Tangible Asset Value70,797,000
Net Current Asset Value70,794,000
Average Receivables213,500
Average Payables273,000
ROIC-6.02%
ROE-0.03%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.10, and the price to book ratio, 0.10, reflect the market's valuation relative to the company's book value. Ratios like price to free cash flows, -3.16, and price to operating cash flows, -3.11, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.10
Price to Book Ratio0.10
Price Cash Flow Ratio-3.11
Enterprise Value Multiple-12.94
Price Fair Value0.10
Price to Operating Cash Flow Ratio-3.11
Price to Free Cash Flows Ratio-3.16
Price to Tangible Book Ratio0.69
Enterprise Value Over EBITDA3.66
EV to Operating Cash Flow9.38
Earnings Yield-3.89%
Free Cash Flow Yield-4.85%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Forward Pharma A/S (FWPAY) on the PNK in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -3.876 in 2024.

What is the ticker symbol of Forward Pharma A/S stock?

The ticker symbol of Forward Pharma A/S stock is FWPAY.

What is company IPO date?

IPO date of Forward Pharma A/S is 2014-10-15.

What is company current share price?

Current share price is 300.000 USD.

What is stock market cap today?

The market cap of stock today is 7445700.000.

What is PEG ratio in 2024?

The current -0.001 is -0.001 in 2024.

What is the number of employees in 2024?

In 2024 the company has 4.